Concepedia

Christopher Kalberg

CK

15

Publications

1.3K

Citations

14

H-Index

1988

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (Netherlands)

The University of Texas Health Science Center at San Antonio

University of North Carolina at Chapel Hill

Christopher Kalberg is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and asthma.

Top concepts

Publications per year

1988–2014

15

Publications

15

Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations

Gary T. Ferguson, Antonio Anzueto, Richard Fei et al. · Respiratory Medicine · 2008 · 245 citations · Full text

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

Antonio Anzueto, Gary T. Ferguson, Greg Feldman et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2009 · 187 citations

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma

John J. Condemi, Stanley Goldstein, Christopher Kalberg et al. · Annals of Allergy Asthma & Immunology · 1999 · 152 citations

, , +7

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

William W. Busse, Harold S. Nelson, James Wolfe et al. · Journal of Allergy and Clinical Immunology · 1999 · 144 citations · Full text

, , +5

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations

Jonathan Matz, Amanda Emmett, Kathleen Rickard et al. · Journal of Allergy and Clinical Immunology · 2001 · 129 citations · Full text

, , +4

Rows per page

1–5 of 15